Literature DB >> 17879587

Is esophageal dysmotility after laparoscopic adjustable gastric banding reversible?

Enrico Facchiano1, Stefano Scaringi, Jean-Marc Sabate, Mohamed Merrouche, Pauline Jouet, Benoit Coffin, Simon Msika.   

Abstract

Laparoscopic adjustable gastric banding (LAGB) has become an increasingly popular option to treat morbid obesity. Esophageal dysmotility secondary to LAGB has been described, but is usually reversible after removal of the band. Long-term esophageal dysmotility persisting after removal of the band is an unusual and not yet described complication. We report the case of a 58-year-old obese patient who developed severe dysphagia and vomiting associated with atypical esophageal dysmotility 22 months after gastric band placement. Radiological exploration revealed no acute band slippage but only a pseudoachalasia. Device deflation and then band removal were required in an attempt to treat her symptoms. Esophageal dysmotility persisted for several months after band removal and was still present after a Roux-en-Y gastric bypass performed as revisional operation. Possible mechanisms generating this complication and clinical implications are discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17879587     DOI: 10.1007/s11695-007-9127-x

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  22 in total

1.  Experimental esophagitis affects intracellular calcium stores in the cat lower esophageal sphincter.

Authors:  H Rich; U D Sohn; J Behar; N Kim; P Biancani
Journal:  Am J Physiol       Date:  1997-06

2.  Re-operations following laparoscopic adjustable gastric banding.

Authors:  Ralph Peterli; Andrea Donadini; Thomas Peters; Christoph Ackermann; Peter Tondelli
Journal:  Obes Surg       Date:  2002-12       Impact factor: 4.129

3.  Effect of laparoscopic gastric banding on esophageal motility.

Authors:  J R de Jong; B van Ramshorst; R Timmer; H G Gooszen; A J P M Smout
Journal:  Obes Surg       Date:  2006-01       Impact factor: 4.129

4.  Histopathologic features in esophagomyotomy specimens from patients with achalasia.

Authors:  J R Goldblum; T W Rice; J E Richter
Journal:  Gastroenterology       Date:  1996-09       Impact factor: 22.682

5.  Esophageal dilatation after laparoscopic adjustable gastric banding: definition and strategy.

Authors:  Jérôme Dargent
Journal:  Obes Surg       Date:  2005 Jun-Jul       Impact factor: 4.129

6.  Manometric abnormalities and gastroesophageal reflux disease in the morbidly obese.

Authors:  Dennis Hong; Yashodhan S Khajanchee; Natasha Pereira; Barbara Lockhart; Emma J Patterson; Lee L Swanstrom
Journal:  Obes Surg       Date:  2004 Jun-Jul       Impact factor: 4.129

7.  Abnormal esophageal acid exposure is common in morbidly obese patients and improves after a successful Lap-band system implantation.

Authors:  P Iovino; L Angrisani; F Tremolaterra; E Nirchio; M Ciannella; V Borrelli; F Sabbatini; G Mazzacca; C Ciacci
Journal:  Surg Endosc       Date:  2002-06-20       Impact factor: 4.584

Review 8.  Gastrointestinal disturbances with obesity.

Authors:  R J Lieverse; J B Jansen; A A Masclee; C B Lamers
Journal:  Scand J Gastroenterol Suppl       Date:  1993

9.  Revision of failed laparoscopic adjustable gastric banding to Roux-en-Y gastric bypass.

Authors:  B van Wageningen; F J Berends; B Van Ramshorst; I F M Janssen
Journal:  Obes Surg       Date:  2006-02       Impact factor: 4.129

Review 10.  Changes in comorbidities and improvements in quality of life after LAP-BAND placement.

Authors:  John B Dixon; Paul E O'Brien
Journal:  Am J Surg       Date:  2002-12       Impact factor: 2.565

View more
  2 in total

1.  Reversible pseudoachalasia in a patient with laparoscopic adjustable gastric banding.

Authors:  Seth Lipka; Seymour Katz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-07

2.  About the Diagnosis and Management of Functional Heartburn: Heartburn and Oesophageal Motility Disorders.

Authors:  Stefano Scaringi; Francesco Giudici; Paolo Bechi
Journal:  Am J Gastroenterol       Date:  2016-08       Impact factor: 10.864

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.